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Abstract
Background: Ethnic differences in human DNA methylation have been shown for a number of CpG sites, but the
genome-wide patterns and extent of these differences are largely unknown. In addition, whether the genetic
control of polymorphic DNA methylation is population-specific has not been investigated.
Results: Here we measure DNA methylation near the transcription start sites of over 14, 000 genes in 180 cell lines
derived from one African and one European population. We find population-specific patterns of DNA methylation
at over a third of all genes. Furthermore, although the methylation at over a thousand CpG sites is heritable, these
heritabilities also differ between populations, suggesting extensive divergence in the genetic control of DNA
methylation. In support of this, genetic mapping of DNA methylation reveals that most of the population
specificity can be explained by divergence in allele frequencies between populations, and that there is little overlap
in genetic associations between populations. These population-specific genetic associations are supported by the
patterns of DNA methylation in several hundred brain samples, suggesting that they hold in vivo and across
tissues.
Conclusions: These results suggest that DNA methylation is highly divergent between populations, and that this
divergence may be due in large part to a combination of differences in allele frequencies and complex epistasis or
gene × environment interactions.
Background
In multicellular organisms, the great diversity of cell
types is maintained by mitotically heritable differences
in gene expression, which are in part regulated by epige-
netic mechanisms [1]. These include histone modifica-
tions, histone variants, RNA-based mechanisms, and
DNA methylation [2]. The latter is perhaps the best
understood component of the epigenetic machinery [3]
and in somatic cells occurs almost exclusively on cyto-
sine residues in the context of CpG dinucleotides [4].
While CpGs are underrepresented across the human
genome, they are enriched at the majority of gene pro-
moters, forming regions known as CpG islands that can
regulate the expression of neighboring genes [4]. DNA
methylation is not only closely linked to tissue-specific
gene expression, but also to a number of intriguing bio-
logical phenomena such as X-chromosome inactivation
in females, allele-specific expression of imprinted genes,
aging, and cancer [5].
An emerging aspect of epigenetics is its role at the
interface between the environment and the genome [6].
Although DNA methylation is a very stable epigenetic
mark, numerous environmental influences have been
associated with variation in DNA methylation as well as
other epigenetic marks [2,6]. These include nutritional
factors, exposure to environmental pollutants, and social
environment. It is this plasticity that underlies much of
the potential contribution of DNA methylation to multi-
factorial diseases and complex phenotypes [7]. However,
the fundamental biology of the epigenome poses some
challenges to testing this attractive concept. For exam-
ple, most primary material available from human popu-
lations consists of mixtures of different cell types with
distinct epigenomes, making it difficult to specifically
assess the association of epigenetic changes with envir-
onmental exposure and phenotype. To address the role
of epigenetics in common disease, it is important to
understand the nature of epigenetic variation in the con-
text of genetically well-characterized pure cell
populations.
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measuring DNA methylation have allowed the patterns
of methylation to be characterized throughout the
human genome [8-15]. Comparing these results between
twins has revealed that methylation at some CpG sites
can be heritable [14,15], and combining them with gen-
otype data has led to the discovery of hundreds of
methylation-associated SNPs, or ‘mSNPs’, in brain tissue
[11,12] as well as cell lines [13]. However, the question
of whether the effects of mSNPs on DNA methylation
levels and heritability differ between human populations
has not been addressed. Quantifying such population
specificity is important for our understanding of the
genetic architecture of the epigenome, as well as its
plasticity during human evolution.
Results
To compare DNA methylation between human popula-
tions, we utilized lymphoblastoid cell lines (LCLs) from
the HapMap project [16], which have been extensively
genotyped and previously employed to study the popula-
tion specificity of gene expression levels [17-19].
Although LCLs can acquire changes in gene expression
and DNA methylation during transformation and cell
culture [20,21], it has been shown that the inter-indivi-
dual variation - which is what is relevant for the current
work - is nearly always conserved (at least for gene
expression) [21]. Our initial study set consisted of 30
family trios (mother/father/offspring) of Northern Eur-
opean ancestry (abbreviated CEU), and 30 trios of Yoru-
ban (West African) ancestry (abbreviated YRI). These
180 cell lines were grown in identical conditions and
their genomic DNA was subjected to quantitative bead-
array-based DNA methylation analysis at 27, 578 CpG
sites near the transcription start sites of 14, 495 genes
(Materials and methods). Although an average of
approximately two CpG sites near each transcription
start site does not directly measure most of the methyla-
tion in regulatory regions, the fact that sites separated by
under approximately 1 kb show highly correlated methy-
lation [9,10] suggests that our data may actually capture
the majority of methylation information near transcrip-
tion start sites - similar to the effect of linkage disequili-
brium (LD) between genetic variants in genome-wide
association studies (though there is no guarantee that the
most relevant sites will be in ‘methylation LD’ with the
CpG sites we measure). The 1, 092 sites on the × and Y
chromosomes were excluded from all analyses to elimi-
nate gender effects, leaving 26, 486 autosomal sites in 13,
890 genes (in which no significant sex specificity was
observed; Figure S1 in Additional file 1).
The resulting data revealed a wide range of within-
population variability in the methylation of individual
CpG sites (Figure 1a), consistent with previous work
[11-13]. Across all sites, the average correlation of
methylation profiles between individuals (mean r
2 = 0.78
for CEU, 0.86 for YRI) was far lower than that of techni-
cal replicates (r
2 > 0.99 for all six replicate pairs), indi-
cating that most of the variability was biological, and
not technical. In addition, we replicated results for two
variable sites in all 180 samples by pyrosequencing
bisulfite-treated DNA. This showed excellent concor-
dance with our array-based results (r
2 =0 . 8 8f o rIGSF2
and 0.94 for PLSCR2; Figure 1b), suggesting that the
array data provide accurate quantification of DNA
methylation levels.
In addition to the variation within each population, we
observed extensive differences in the DNA methylation
patterns between populations (for example, FLJ32569 in
Figure 1a). To quantify this population specificity, we
calculated the number of CpG sites with methylation
differing between populations, using the nonparametric
Wilcoxon test. We found a substantial fraction differing
between the populations (Figure 1c): at nominal P <
0.01, 8, 475 sites differed between populations (32.0% of
sites; false discovery rate (FDR) = 3.1%), and 5, 654 sites
remained significant at P < 0.001 (21.4% of sites; FDR =
0.5%; Figure S2 in Additional file 1). Thus, the methyla-
tion of approximately 30% of the CpG sites we studied -
representing over a third of the genes assayed - differed
between populations (this degree of population specifi-
city is similar to that of gene expression levels in the
same cell lines; Figure S3 in Additional file 1). However,
these population-level differences tended to be small in
magnitude, with only 1, 033 sites (3.9%) differing by an
average of over 10% methylation, and 3, 695 sites
(14.0%) differing by over 5%. Perhaps because of their
small magnitudes, differences in DNA methylation
explained very little of the variation in gene expression
levels between populations that has been previously
reported [17-19] (Supplemental text and Figure S4 in
Additional file 1), consistent with previous findings that
inter-individual variation in DNA methylation explains
almost none of the variation in gene expression [12,13].
These subtle but extensive epigenetic differences
between populations could have genetic or environmen-
tal underpinnings - or a combination of both. To assess
the role of both common and rare genetic variants in
determining DNA methylation patterns, we estimated
the contribution of additive genetic variation (known as
narrow-sense heritability, or h
2) to the methylation of
each CpG site in each population by measuring the cor-
relation in methylation levels between parents and their
offspring (Figure 2a; Materials and methods). We
observed heritable methylation at approximately 762
CpG sites in CEU and 930 sites in YRI (Figure 2b), sug-
gesting that genetic control of polymorphic methylation
is fairly common - though slightly less heritable than
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Page 2 of 12Figure 1 Population-specificity of DNA methylation. (a) Heatmap of the clustered methylation data set. Three representative cases are
magnified: a site with a clear population difference; a site showing within- but not between-population variability; and a site with little variability
within or between populations. (b) We performed pyrosequencing as an independent means to measure methylation of two CpG sites (IGSF2,
chromosome 1, base 117345939; PLSCR2, chromosome 3, base 147696535) in our 180 samples. The agreement validates the accuracy of our
microarray data. (c) The methylation of many sites differs between CEU and YRI. We performed the nonparametric Wilcoxon test to identify CpG
sites differing in methylation between populations. The P-values are skewed towards small values, as shown by comparing to the expected
uniform distribution on either a linear (left) or log (right) scale.
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Page 3 of 12Figure 2 Population specificity of DNA methylation heritability. (a) A ne x a m p l eo faC p Gs i t e( n e a rPLSCR2: chromosome 3, base
147696535) whose methylation is heritable in YRI, but not CEU, as assessed by the similarity of average parental methylation to their offspring
methylation (each point represents one family trio). (b) Histograms comparing the observed distribution of per-site heritabilities to a typical
randomized distribution (numbers in the text are based on 1, 000 randomizations; Materials and methods). The greater number of sites at high
heritabilities in the real data compared to random (arrows) is an estimate of the number of heritable sites we can detect in each population. (c)
No similarity between heritabilities in each population (Pearson’s r
2 = 0.002; each point is a CpG site).
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Page 4 of 12gene expression levels in the same cell lines (Figure S5
in Additional file 1). Given our limited power to detect
weakly heritable DNA methylation, these numbers are
likely to be substantial underestimates of the true extent
of heritability.
Considering the overall genetic similarity among
human populations [16,22], we expected the patterns of
heritability in CEU and YRI to be similar. Surprisingly,
we found almost no correlation between them (r
2 =
0.002; Figure 2c). This is similar to agreement in h
2 for
gene expression levels in the same cell lines (Figure S6
in Additional file 1). We did not find any evidence for
complex inheritance patterns - such as dominance,
maternal-biased, or paternal-biased inheritance of DNA
methylation - that could affect heritability (Supplemental
text in Additional file 1).
Differences in heritability between populations could
have many causes. h
2 is defined as the ratio of a trait’s
additive genetic variance to its total variance in a popu-
lation; factors that can affect this ratio include changes
in the additive genetic variance (for example, differing
allele frequencies), non-additive (gene × gene, or GxG)
genetic variance, environmental variance, and gene ×
environment (GxE) interaction variance [23]. In addi-
tion, limited statistical power could restrict the accuracy
of our heritability estimates (Supplemental text and Fig-
u r eS 7i nA d d i t i o n a lf i l e1 ) .A l t h o u g hw ew e r en o ta b l e
to rule out any of these potential factors, the extensive
DNA sequence data available for these samples do allow
us to test the contributions of two types of divergence
that may contribute to the population-specific DNA
methylation levels, and their heritabilities.
One type of divergence that may affect DNA methyla-
tion levels and heritabilities is a difference in the CEU/
YRI allele frequencies at genetic variants that influence
methylation. In particular, lower minor allele frequency
at such a variant reduces the population-level genetic
variation affecting a site’s methylation, thus reducing h
2.
To test how much of our observed population specificity
can be explained in this way, we first identified the
‘local’ SNP (within 100 kb of the CpG) most strongly
associated with each CpG’s methylation across all 180
samples from both populations (although genetic asso-
ciations in ethnically heterogeneous cohorts such as this
can reflect population stratification, it is appropriate for
our current goal). We then included this single SNP
genotype in a multiple regression analysis to assess
whether genotype or population was a stronger predic-
tor of methylation at each site. Among the 5, 654 CpG
sites differing between populations at Wilcoxon P <
0.001 (discussed above), we found that 3, 131 (55.4%)
were more strongly associated with a local SNP geno-
type than with population, implying that common (and
likely cis-acting) genetic variants can explain over half of
the population specificity we observed. This result also
indicates that most of the population specificity is unli-
kely to be due to any type of cell line artifacts, since
these would not correlate with individual SNP
genotypes.
The second type of divergence we tested concerned
complex GxG or GxE interactions: if a genetic variant is
present in two populations, but affects DNA methylation
in only one, then that variant must genetically interact
with other variants and/or the environment. Such inter-
actions can decrease heritability by increasing the popu-
lation-level variance in DNA methylation (the
denominator of h
2) without affecting the additive genetic
variance (the numerator). To perform this analysis, we
needed to identify SNPs associated with the methylation
of individual CpG sites separately in each population,
and then compare the lists to one another.
Three previous studies of genome-wide DNA methyla-
tion have mapped SNPs whose genotype correlates with
the methylation of a CpG site, termed ‘mSNPs’ [11-13].
Because mSNPs are highly enriched close to their target
CpG sites [11-13], we performed a ‘local’ association
analysis between methylation at each CpG site with all
HapMap SNPs within 100 kb, separately for each popu-
lation. These local mSNP associations can arise from
either true (likely cis-acting) genetic associations, or
genetic variants that disrupt hybridization of the bead-
array probes in some individuals, leading to spurious
associations (analogous to issues in eQTL mapping
[24]). Using recent and essentially complete catalogs of
common genetic variants in each [22], we identified all
probes overlapping variants present in the 1000 Gen-
omes samples (2, 734 probes in CEU, and 3, 923 probes
in YRI; Table S1 in Additional file 1). We observed a
2.6-fold higher frequency of mSNPs for these probes
compared to probes not disrupted by SNPs, implying a
high rate of spurious associations (re-analysis of pre-
viously reported brain mSNPs [11,12] suggests a simi-
larly high rate of spurious associations in those studies).
Therefore, we removed these probes from our analysis
(these sites did not have a higher level of heritability or
population differentiation, so were not excluded from
those analyses; Supplemental text and Figure S8 in
Additional file 1).
After excluding the potentially problematic probes, we
identified 49 mSNPs in CEU and 86 in YRI (genotype
versus methylation level r > 0.6; FDR of 37% and 28%,
respectively), each explaining 36 to 92% of the variance
in DNA methylation at the associated site (Figure 3a).
We note that these numbers are not directly comparable
to previous studies [11,12] that included CpG probes
that may contain SNPs, since including probes overlap-
ping SNPs in our analysis increases the number of
(apparent) mSNPs while decreasing the FDR. Restricting
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Page 5 of 12Figure 3 Population specificity of mSNPs. (a) An example of an mSNP (between a CpG site near LDHC (chromosome 11, base 18390591), and
rs2643856) that is found in both YRI and CEU. In both cases the T allele is associated with higher methylation. (b) Venn diagram of the overlap
among CpG sites associated with an mSNP in YRI and/or CEU. Five CEU sites and eight YRI sites were excluded from the overlap analysis
because they overlapped a SNP in the other population. (c) Example of an mSNP (between a CpG site near PLSCR2 (chromosome 3, base
147696535) and rs12489924) that is found in YRI but not CEU. No other SNPs in CEU within 100 kb of the CpG are associated with methylation
at the site (r < 0.25 for all), indicating that the difference is unlikely to be due to differing LD between rs12489924 and the causal variant. (d)
Scatter plot of all 86 YRI mSNPs, showing the strongest association found for that site in each population. Points are colored according to the
significance of the difference in the associations within each population; most mSNP association strengths are significantly (P < 0.005) different
between populations. The same plot for CEU mSNPs is shown in Figure S10 in Additional file 1. (e) Overlap of LCL mSNPs with brain mSNPs
from two studies of European populations (similar to CEU). Both all CEU mSNPs and CEU-specific mSNPs show similar overlap of 40 to 42%,
which is thus a minimum estimate for the extent of mSNPs shared between LCLs and brain. However, YRI-specific mSNPs show only 3.2%
overlap, not significantly different from the 1.2% expected from any random set of CpG sites.
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(h
2 > 0.2) decreased the FDR substantially (24 mSNPs at
8.6% FDR in CEU; 55 mSNPs at 4.7% FDR in YRI), pro-
viding a high-confidence list of mSNPs (Table 1; Table
S2 in Additional file 1), as well as evidence supporting
our heritability estimates in each population. Our high-
confidence YRI mSNP list overlapped the mSNPs from
a previous study of YRI LCL mSNPs [13] over 50-fold
more than expected by chance (Supplemental text in
Additional file 1). The vast majority of our mSNPs did
not coincide with eSNPs (SNPs associated with gene
expression levels; Supplemental text in Additional file
1), in agreement with previous work [13], suggesting
that most do not impact gene expression levels in stan-
dard LCL culture conditions. None of these mSNPs
affected methylation in known imprinted regions, and
there was no enrichment for Gene Ontology categories
or KEGG (Kyoto Encyclopedia of Genes and Genomes)
pathways among the genes associated with either popu-
lation’s mSNPs.
To test our mSNP mapping accuracy, we performed
bisulfite Sanger sequencing at one mSNP locus
(RNF186; Table 1) on 55 individual DNA molecules
from six samples (three CEU and three YRI; Figure S9
in Additional file 1). Each individual’s average methyla-
tion level at a particular CpG site (cg09195271) agreed
with our array-based results (r
2 = 0.74), recapitulating
the association between this site’sm e t h y l a t i o na n dt h e
genotype of a nearby SNP (rs3806308): individuals with
a CC genotype had the lowest average methylation (4/27
DNA molecules methylated = 14.8%), CT was inter-
mediate (5/18 = 27.8% methylated), and TT had the
highest (8/10 = 80% methylated). Interestingly, the
methylation at six additional CpG sites in between
rs3806308 and the target CpG did not correlate with the
SNP genotype, indicating site-specific control of methy-
lation, and not a more general regional effect.
Comparing our complete catalogs of mSNPs from
each population, we found little overlap between them,
or in the DNA methylation sites associated with mSNPs:
Table 1 High-confidence mSNPs in CEU
Gene Chromosome CpG
position
mSNP Perccentage CEU variance
explained
Perccentage YRI variance
explained
CEU
h
2
YRI
h
2
Brain
mSNP?
TTC13 1 229182620 rs7545429 71.3 49.0 0.41 0.64 No
MGC3207 19 13736014 rs371671 68.8 27.2 0.60 0.35 Yes
PPP4R2 3 73128376 rs9816164 66.7 43.2 0.51 0.23 Yes
LDHC 11 18390591 rs11601413 65.4 86.5 0.55 0.68 Yes
RNF186 1 20015084 rs3806308 65.1 68.3 0.41 0.50 No
FLJ32569 1 204085874 rs823080 58.5 4.5 0.28 0.05 Yes
NDUFAF2 5 60275337 rs162244 57.4 62.6 0.26 0.49 No
PCGF3 4 689950 rs2242234 57.2 19.9 0.47 -0.10 No
LTA 6 31648435 rs2516390 55.9 40.5 0.48 0.24 No
IGSF2 1 117345939 rs12130298 52.6 10.0 0.96 -0.19 No
GSTM5 1 110056139 rs4970776 52.4 12.1 0.55 0.14 Yes
FLJ32569 1 204085802 rs823080 50.4 3.7 0.49 0.08 Yes
ASCIZ 16 79627243 rs16954698 47.8 9.6 0.24 -0.12 No
TACSTD2 1 58815787 rs1109896 42.2 50.4 0.29 0.49 No
HLA-C 6 31347299 rs6457375 42.1 44.0 0.24 0.61 Yes
HLA-
DRB5
6 32606582 rs9271586 42.0 28.2 0.32 0.42 No
LYCAT 2 30523367 rs829650 40.8 52.4 0.75 0.64 Yes
PARK2 6 163069159 rs13218900 40.4 41.6 0.21 0.03 No
ITPR1 3 4510075 rs304075 39.4 7.6 0.21 -0.07 No
PSMD5 9 122644335 rs12343516 39.4 35.1 0.53 0.11 Yes
BTN3A2 6 26472772 rs2393667 38.1 14.9 0.22 0.31 Yes
RAPGEF3 12 46439111 rs3759407 37.2 6.8 0.71 -0.17 No
FAM83A 8 124264314 rs16898095 36.3 76.5 0.27 0.71 No
CRIP2 14 105011436 rs4983346 36.1 3.6 0.46 0.04 No
The 24 mSNP-CpG site pairs where > 36% of the variance in CEU methylation is explained by the mSNP genotype, and h
2 > 0.2. When more than one SNP was
tied for the strongest association (due to perfect LD), one was chosen randomly. The YRI association strength is for the top local (within 100 kb) mSNP
association for the same CpG site. In bold are YRI associations that explain < 20% of the variance in YRI methylation, indicating a high-confidence set of CEU-
specific associations. For brain mSNPs, the intersection of cis-acting mSNP lists used by the authors of each original study [11,12] was used. YRI mSNPs are listed
in Table S2 in Additional file 1.
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Page 7 of 12only 11 CpG sites (8.9% of the mSNP-associated sites)
were present in both of our medium-confidence lists
(Figure 3a-c). This lack of overlap parallels the extensive
population specificity of both methylation levels (Figure
1c) and their heritabilities (Figure 2c). Sites with popula-
tion-specific mSNPs also tended to have population-spe-
cific heritabilities (Table 1, entries in bold; and see
PLSCR2 in Figure 2a and 3b), suggesting that the
mSNPs we detect are a major source of the heritability
of their target sites’ methylation.
Three factors could contribute to a lack of overlap
between mSNPs from each population: low power, dif-
fering LD/allele frequencies, and true population-specific
effects of genetic variation on methylation. We found
that neither low power nor differing LD/allele frequen-
cies could account for most of the population specificity
we observed (Supplemental text in Additional file 1),
suggesting that many mSNPs exert population-specific
effects on DNA methylation. Such population specificity
can only be explained by interactions between the
mSNPs and other genetic variants, and/or the environ-
ment (see Discussion).
Comparing our mSNP catalogs to previously reported
mSNPs from brain allows us to test the generality of the
observed population specificity in an independent cohort
and tissue. Among our CEU mSNPs, 42% (10/24; Figure
3e) were previously observed in both of two brain
mSNP catalogs that utilized cohorts of European ances-
try [11,12] (Table 1), indicating that these associations
are shared across tissues. A similar fraction (4/10, 40%;
Figure 3e; Table 1, entries in bold) of the subset of
high-confidence mSNPs observed only in CEU (not YRI)
were also seen in brain. A key prediction of our results
is that mSNPs found only in YRI should not be
observed in the European brain samples if they are truly
population specific. In support of this, only 1/32 (3.1%;
Figure 3e; Table S1 in Additional file 1) of YRI-specific
mSNPs were seen in European brain (not significantly
different than the 1.2% expected by chance). This lack
of overlap is unlikely to be due to potential artifacts of
long-term cell culture, since the CEU cell lines are dec-
ades older than the YRI, which would tend to act
against the trend we observed. Therefore, we conclude
that the population specificity we discovered is recapitu-
lated in vivo, as well as across tissues.
Discussion
Our results demonstrate extensive population specificity
in DNA methylation profiles near transcription start
sites. We observed these differences at three levels: the
extent of DNA methylation, its heritability, and its asso-
ciation with specific genetic variants (mSNPs). We attri-
bute most of these differences to two main factors:
population-specific allele frequencies of genetic variants
affecting DNA methylation, and complex GxG or GxE
interactions.
Although in vitro artifacts are always a concern when
using cell lines - and in particular LCLs, which have been
shown to have some methylation differences compared
to blood [20,21] - our results are unlikely to be driven by
these effects, for three main reasons. First, unlike some
previous studies of population-level differences in these
cell lines [17,25], we processed samples in a randomized
design, to eliminate the possibility of batch effects influ-
encing our estimates of population specificity. Second,
we found most of the population-specific DNA methyla-
tion to be explained by local genetic variants, ruling out
any type of cell line artifact as an alternative explanation.
Third, and most importantly, our population-specific
mSNPs are supported by comparison to two studies of
brain mSNPs in cohorts of European ancestry: 40% of
our CEU-specific mSNPs overlap with both of these pre-
vious studies, whereas only 3.1% of YRI-specific mSNPs
do, despite our expectation that the much older CEU
LCLs would be more likely to have accumulated abnorm-
alities in DNA methylation [20]. Together, these lines of
evidence strongly suggest that our results apply in vivo
and across tissues.
A variant that is present in two populations, but
affects DNA methylation in only one, can only be
explained by complex genetic interactions. These inter-
actions could involve the environment (GxE), epistasis
w i t ho t h e rv a r i a n t s( G x G ) ,o rb o t h .F o re x a m p l e ,s o m e
genetic variants have an observable effect on DNA
methylation only in the presence of a sufficient quantity
of methyl donors [26], which could differ between Yoru-
bans and European-Americans as a result of diet or
other factors (though methylation differences due to
GxE interactions would have to be preserved during the
creation and culturing of the LCLs). Even with such
interactions causing differentiation between populations,
genetic effects could be entirely additive within popula-
tions, consistent with our observation of heritable DNA
methylation at many sites.
Divergence in the genetic underpinnings of DNA
methylation (as evidenced by the population-specific
mSNPs) would be expected to result in differing herit-
abilities and methylation levels, consistent with our
results. Although we cannot provide an accurate esti-
mate of exactly how much of the population-specific
DNA methylation we observed is due to population-spe-
cific mSNPs, it is likely to be a substantial fraction once
mSNPs of small effect (which could not be detected
here due to our limited sample size) are accounted for.
Conclusions
As DNA methylation is an important epigenetic modifi-
cation, affecting a wide range of diseases and other
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mental interactions likely affect most mSNPs - and thus
may also explain a substantial portion of the population
specificity of DNA methylation levels, and their herit-
abilities - underscores the complex interplay of factors
that influence epigenetic modifications. Further charac-
terization of these factors will be critical for our under-
standing of the epigenome.
Materials and methods
Genome-wide DNA methylation analysis
Genomic DNA was purchased from the Coriell Institute.
DNA concentration and purity were assessed spectro-
photometrically using a NanoDrop ND-1000 (Thermo
Scientific, Waltham, MA, USA). After random ordering
of all samples, 1 μg of genomic DNA from each sample
was bisulfite-converted using the EZ-96 DNA Methyla-
tion Kit (Zymo Research, Irvine, CA, USA) as per Illu-
mina’s Infinium specific protocol. Bisulfite converted
DNA was then quantified by NanoDrop and concen-
trated to higher than 50 ng/μl using a Speedvac.
Quantitative DNA methylation measurements of bisul-
fite-treated genomic DNA were performed with the Infi-
nium HumanMethylation27 BeadChip assay (Illumina,
San Diego, CA, USA), using experimental procedures
recommended by the manufacturer. Briefly, 200 ng of
bisulfite-converted DNA was whole-genome amplified,
fragmented by an enzymatic process and hybridized to
BeadChip arrays. Two oligonucleotide probes interro-
gated each CpG site, one probe with sequences targeting
methylated DNA and the other containing sequences
targeting unmethylated DNA. After extension with
DNP-labeled and biotin-labeled dNTP, each array was
stained with Cy5 labeled anti-DNP antibodies and Cy3
labeled streptavidin and scanned with the Illumina iScan
on a two-color channel to detect Cy3 labeled probes on
the green channel and Cy5 labeled probes on the red
channel. Using the Illumina GenomeStudio software
package, methylation levels (b values) were then calcu-
lated by dividing the methylated probe signal intensity
by the sum of methylated and unmethylated probe sig-
nal intensities. b values range from 0 (completely
unmethylated) to 1 (fully methylated) and provide a
quantitative readout of relative DNA methylation for
each CpG site within the cell population being interro-
gated. This method was highly reproducible, as technical
replicates across different runs had r > 0.996. All sam-
ples passed internal controls included on the Human-
Methylation27 arrays, including controls for array
background, hybridization quality, target specificity and
bisulfite conversion. Furthermore, all samples passed
our quality control check of having fewer than 5% of
sites with either detection P-value < 0.05 or fewer than
five beads being present on the array for a particular
CpG site. Cluster analysis also indicated the absence of
any outlier samples. Raw data have been deposited in
the Gene Expression Omnibus database under accession
number [GSE27146].
Samples from both populations were run together in a
randomized order to avoid confounding batch effects
with population differences. In order to test for the pre-
sence of batch effects, we tested whether the DNA
methylation profiles of samples run in either the same
batch number (1 to 4) or well number (1 to 96) were
more similar to each other than expected by chance.
Neither batch number nor well number was predictive
of profile similarity (comparing correlation coefficients
within batches or wells to all sample correlations, Wil-
coxon P = 0.79 and 0.64, respectively), indicating the
lack of any detectable batch effects.
Several steps were applied for normalization of b
values across the subjects. First, average background
intensity, as measured by negative background probes
present on the array, was subtracted from the raw inten-
sities to adjust for varying background signals across dif-
ferent samples. This background adjustment was done
separately for raw data from the green and red channels
to adjust for Cy3 and Cy5 differences. All negative
intensities were assigned values of zero before further
normalizations were performed. To minimize batch
effects across different sets of arrays, background
adjusted raw data from both channels were quantile
normalized separately. Applying the same formula used
by GenomeStudio, average b values were then recalcu-
lated using background subtracted and quantile normal-
ized intensities of methylated probes divided by the sum
of normalized intensities from unmethylated and methy-
lated probes.
Pyrosequencing
DNA methylation of the promoter regions of PLSCR2
and IGSF2 containing specific CpG loci under the con-
trol of mSNPs were confirmed using bisulfite pyrose-
quencing. Genomic DNA (750 ng) was bisulfite
converted using an EZ DNA Methylation Gold kit
(Zymo Research). After PCR amplification of approxi-
mately 200 bp regions encompassing the target loci
using specifically designed primers to ensure unbiased
amplification, quantitative measurement of DNA methy-
lation at each CpG was performed using a pyrosequen-
cing primer located within 30 bp of the CpG
interrogated. Reactions were measured on a PyroMark
Q96 MD Pyrosequencer following the manufacturer’s
protocol, and analyzed using the Pyro Q-CpG software
(Biotage, Uppsala, Sweden), which allows quality assess-
ment of each measurement. CpG loci that were called
‘passed’ in the default software settings are shown in
Figure 1b (n =1 7 5f o rIGSF2; n =1 5 6f o rPLSCR2). To
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son’sc o r r e l a t i o n( a st h r o u ghout the manuscript),
because rank-based correlations do not account for the
clustering of most samples within a small range of
methylation (for example, 95 to 100% methylation for
PLSCR2 in Figure 1b). An alternative metric, classifying
sites into high or low methylation based on a cutoff and
measuring agreement in a 2 × 2 contingency table, led
to results similar to the Pearson correlation across a
wide range of cutoffs (data not shown). Primer
sequences used for DNA amplification and pyrosequen-
cing are available upon request.
Calculation of false discovery rates
All FDRs were estimated by randomization, which pre-
serves all aspects of the data that might affect statistical
analyses. For example, the FDR for population-specific
methylation was estimated by randomly assigning CEU/
YRI labels, and recalculating the Wilcoxon P-value on
the randomized data (resulting in an essentially uniform
distribution of P-values, like that shown in Figure 1c).
FDRs for mSNPs were estimated by pairing genotypes
with randomly chosen methylation profiles, and calculat-
ing mSNPs as for the real data. Because of the family
trio structure of the HapMap samples, not all samples
are independent; to account for this in our randomiza-
tion procedure, we also performed randomizations
based on swapping methylation data for entire trios, in
effect treating each trio as an independent unit com-
posed of three methylation profiles and three genome
sequences. This procedure yielded indistinguishable
FDRs compared to randomizing all samples individually.
All FDRs are based on at least 1, 000 randomizations.
Heritability analysis
Narrow-sense heritabilities (h
2) were estimated as the
correlation between average parental values and their
offspring. Because the offspring and parental variances
are equal, this is equivalent to performing regression.
Although heritabilities are by definition non-negative,
our estimates are often negative due to the limited
power inherent in our data. We note that our method
of estimating h
2 assumes that there is no shared envir-
onmental variance between parents and offspring that
impacts DNA methylation; if this assumption is violated,
we will overestimate h
2 (with an upper bound of H
2,t h e
broad-sense heritability). It also assumes that somatic
D N Am e t h y l a t i o ni sn o tp a s s e dd i r e c t l yf r o mp a r e n tt o
offspring through the germline, since this would violate
the assumptions of the heritability estimation. To esti-
mate the number of CpG sites with heritable methyla-
tion, we generated 1, 000 randomized versions of the h
2
distribution (see above), and calculated the number of
sites with greater methylation in the real data, compared
to each randomized distribution. Visually, this corre-
sponds to the area in between the two distributions, on
the right side (positive values) where the real distribu-
tion is shifted to the right. The average difference across
the 1, 000 randomizations was 762 sites for CEU, and
930 for YRI. Note that this procedure allows us to esti-
mate the number of heritable sites, but not specify
which specific sites are the heritable ones; thus, it is not
possible to calculate an FDR for these estimates.
mSNP analysis
mSNPs were identified by calculating correlations
between SNP genotypes (arbitrarily coded as 0, 1, and 2)
and methylation levels. Only SNPs within 100 kb of
each CpG site were tested, to reduce the multiple test-
ing burden. Although the 1000 Genomes SNP catalog is
more complete, we used HapMap genotypes [16] for the
mSNP analysis, since not all cell lines for which we col-
lected methylation data have been sequenced as part of
the 1000 Genomes Project [22]. We required a mini-
mum of 5 minor alleles among the 90 individuals of
each population to include a SNP in this analysis (for
details of how we accounted for the family trio struc-
ture, see ‘Calculation of false discovery rates’ above).
This resulted in 2, 668, 982 YRI SNPs and 2, 405, 735
CEU SNPs (1, 969, 973 shared by both). For the analysis
of genetic variants contributing to population-level dif-
ferences, only the SNPs shared by both populations
were used, and population was represented in the multi-
ple regression as 0/1 for CEU/YRI.
Correlations were recorded as the absolute value of
the correlation coefficient, since the sign is arbitrary,
depending on how genotypes are coded as 0/1/2. How-
ever, for comparisons between CEU and YRI correla-
tions, the fact that all correlations are positive means
that the difference between associations can be underes-
timated. If the same SNP (or two SNPs in high LD) was
used to calculate the correlation with a particular CpG
site’s methylation in both populations, the signs could
be used; however, in most cases a site’ss t r o n g e s tc o r r e -
lation was with different SNPs in CEU and YRI, pre-
cluding the use of signs.
Bisulfite sequencing of RNF186 promoter region
Genomic DNA (500 ng) was bisulfite converted using
the EZ-96 DNA Methylation Gold Kit (Zymo Research)
as per the manufacturer’s protocol with minor modifica-
tions. A 532 bp region upstream of the RNF186 gene
containing the SNP rs3806308 and the CpG site
cg09195271 from the IlluminaHuman Methylation array
was amplified by nested PCR reactions using Hotstar
Taq (Qiagen, Hilden, Germany). The first round of PCR
amplification was done using5 5 ° Ca n n e a l i n gt e m p e r a -
ture for 30 cycles and the primer pair F3
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R2 (ACRCACAAATATTTAACACCTACTACT). A 3 μl
aliquot of the material obtained in the first round was
further amplified in the second round in a total volume
of 50 μl, using 51°C annealing temperature for 35 cycles
and the primer pair F2 (TGAATGAAATATTTGTTT-
GAGGGAGTGT) and R3 (CCTTAAAACCACAAC-
TATTATATTCACAA). All primers were designed to
be specific for bisulfite converted DNA. The amplified
PCR product was separated from primers by electro-
phoresis in a 1.5% Tris-acetate-EDTA (TAE) agarose
gel, excised and purified using the QIAquick gel extrac-
tion kit (Qiagen). Purified DNA was then ligated into
plasmid pGem-T Easy using the pGem-T Easy vectory
system (Promega, Madison, WI, USA) and transformed
into competent JM109 Escherichia coli (Promega) by the
CaCl2 method. Colonies carrying a plasmid containing
an insert were then selected based on blue-white screen-
ing. Plasmid DNA was extracted using Qiaprep Spin
Miniprep kit (Qiagen). Plasmid clones containing the
appropriate sized insert, as determined by a restriction
digestion analysis, were sequenced using T7 and/or SP6
primers by Genewiz Inc. South Plainfield, NJ, USA.
Sequences were analyzed using Sequencher sequence
analysis package 4.6 (Gene Codes Corporation, Ann
Arbor, MI, USA).
Additional material
Additional file 1: Supplemental text, Tables S1 and S2, and Figures
S1 to S19 [27-30].
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